sc451
sc451: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sana Biotechnology, Inc. (SANA) | Preclinical |
FDA Decisions
FDA_MeetingIncreases confidence in moving forward with HIP-edited master cell bank for GMP manufacturing and non-clinical testing plan.(SANA)
Frequently asked questions
Who is developing sc451?
sc451 is being developed by Sana Biotechnology, Inc..
What is sc451's latest FDA decision?
The most recent tracked FDA decision for sc451 is FDA_Meeting for Increases confidence in moving forward with HIP-edited master cell bank for GMP manufacturing and non-clinical testing plan..
Get deeper analysis on sc451
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis